Evidence map›Paper›PMID 42714438›Full record

ReviewAJR. American journal of roentgenology2026

Artificial Intelligence Across the PET Reconstruction Pipeline: An Update.

Faraz Farhadi, Jayasai R Rajagopal, Sean Ide Bolet, Joyita Dutta, Onofrio A Catalano, Amir Iravani, Shadi A Esfahani, Hossein Jadvar, Pedram Heidari

Abstract readReview
In one paragraph

Review in AJR. American journal of roentgenology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Faraz FarhadiDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Jayasai R RajagopalOak Ridge National Laboratory, Oak Ridge, TN, USA.
Sean Ide BoletDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Joyita DuttaDepartment of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA, USA.
Onofrio A CatalanoDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Amir IravaniDivision of Nuclear Medicine, Department of Radiology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Shadi A EsfahaniDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Hossein JadvarDivision of Nuclear Medicine and Molecular Imaging Center, Departments of Radiology, Radiation Oncology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Pedram HeidariDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.

Funding

Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal AdenocarcinomaK08CA259626 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Shadi Abdar Esfahani · 2022 to 2026
$1.3M
NCI NIH HHS K08 CA259626
6 · The paper itself

Abstract

PET reconstruction has evolved from analytic and iterative physics-based methods toward hybrid approaches that increasingly incorporate artificial intelligence (AI). As digital detectors, long-axial FOV systems, and time-of-flight technology increase data richness and computational demand, AI, particularly deep learning, is being used across the acquisition, correction, reconstruction, and postprocessing stages to stabilize low-count imaging, refine system modeling, and improve noise-resolution tradeoffs while preserving clinically relevant image interpretation. In this context, most AI methods function to augment-rather than replace-established physics-based reconstruction frameworks. Early clinical and multicenter studies have demonstrated that selected AI-based methods maintain noninferior diagnostic performance and key quantitative metrics within defined acquisition and reconstruction contexts. As these tools transition from research into routine practice, their implementation is shaped by intended-use validation, interoperability, traceability, and software lifecycle management requirements. This Review explores the application of AI across the PET reconstruction pipeline, discussing technical foundations, highlighting key clinical implications, and considering regulatory and other practical issues that govern safe and reproducible deployment. Reconstruction pipeline steps considered in the article include mathematical inversion of projection data into images, signal processing during acquisition, prereconstruction corrections, system modeling incorporated into reconstruction, and postreconstruction processing steps that directly influence reconstructed image properties.

Identifiers

PMID42714438
PMCPMC13676307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.